An MP diagnosed with breast cancer for a second time wants to "debunk" misconceptions about metastatic cancers. Labour MP for ...

Fatigue is a very common symptom of metastatic breast cancer, and it can significantly impact quality of life. Here are ways ...

Caring for someone with metastatic breast cancer can be demanding physically, emotionally, and financially, but there are ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...

The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...

AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo.

An increasing number of younger women are being diagnosed with breast cancer despite the common misconception it is an older ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Invasive lobular breast cancer is a silent killer. I deserved to have an early diagnosis; I did not get this. I deserve a ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's (OTCPK:DSKYF) drug Enhertu has been approved by the FDA for the treatment of certain breast cancer patients. Enhertu was approved for the treatment of ...